← Open Payments lookup

MARY FIL: Open Payments

NPI 1154915643 · TUSCALOOSA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,543 in 85 payments from 15 companies in 2025. Trend: 2023 $1,018 · 2024 $1,077 · 2025 $1,543

Food & beverage: $1,543
CompanyPaymentsAmount
ABBVIE INC.29$464
Ardelyx, Inc.9$177
Salix Pharmaceuticals, a division of Bausch Health US, LLC9$155
Madrigal Pharmaceuticals5$139
Janssen Biotech, Inc.7$131
Takeda Pharmaceuticals U.S.A., Inc.7$116
PFIZER INC.5$81
Aimmune Therapeutics, Inc.4$68
Ipsen Biopharmaceuticals, Inc2$58
QOL Medical, LLC2$49

Products named: RINVOQ, IBSRELA, XIFAXAN, REZDIFFRA, TREMFYA, LINZESS, ENTYVIO, XELJANZ.

Industry payments across AL — which companies pay providers there.